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Abstract 
A previously well older man died three weeks after presenting with confusion and hallucinations. Dr 
Chataway discusses the differential diagnosis of rapidly progressive cognitive symptoms, based on 
his presentation at the 36th Edinburgh Advanced Neurology Course 2014. 
History 
An 83 year old man presented as an emergency with rapidly emerging confusion and visual 
hallucinations. His family had noted mild cognitive symptoms for a year or two, but he was living 
independently, and had recently enjoyed a family celebration.  
He was in good health and his past medical history included angina and a cholecystectomy and 
transurethral prostatectomy. Eight years previously, his GP had noted an isolated episode when he 
awoke confused, making “out of context” comments about money to his wife. A CT head was 
reported as mildly atrophic for age, and he was referred to a psychogeriatrician, but he was never 
assessed as he recovered fully after this isolated episode.  He was on no regular medication at the 
time of this admission. 
On assessment his Abbreviated Mental Test (AMT) was 9/10 with a normal neurological 
examination. The following day he appeared more confused and agitated, and was treated with 
lorazepam and haloperidol. Two days later he was transferred for rehabilitation, with a diagnosis of 
delirium, possibly due to infection (see Table 1 for a summary of investigations).  
On the rehabilitation ward, he was recorded to be “drowsy and disorientated in time and place”. He 
had two falls over the next few days, but no new symptoms or signs were noted. On the fifth day of 
his admission, he became hypotensive and atrial fibrillation with a rapid ventricular rate was 
identified. A neurologist saw him the following day, and noted dysarthria with slurred, nasal speech, 
but no other focal signs. His conscious level and degree of confusion fluctuated, and on day 9 some 
myoclonic jerks were noted.  Later that day he was transferred to the regional Neurosciences unit 
for further assessment, including MR head. Imaging was postponed however, as his airway was 
unsafe and soon after transfer, his airway safety deteriorated further, and he was intubated and 
ventilated (it was reasoned that although his prognosis was probably poor, there was no diagnosis). 
Further investigations were undertaken. He was given a single course of high dose intravenous 
methylprednisolone, without effect.  After discussion with the family, it was decided to extubate 
him, and he died 24 hours later, on day 20 after admission to hospital. A limited post mortem was 
performed. 
Admission investigations 
Radiology                                             Blood tests                                              Others 
 Chest Xray : normal  
 CT head (day 2): within 
normal limits for age, 
no evidence of 
significant small vessel 
disease. 
 FBC, ESR, clotting screen, 
electrolytes, creatinine, liver 
and thyroid function tests, 
calcium, albumin, creatine 
kinase - normal 
 Urea 10.8 mmol/L (2.5-6.6) 
 Urine culture: normal 
 
Days 5 – 8 of illness 
 Chest Xray bilateral 
basal consolidation 
with progression 
between day 5 and 8. 
 CT head (day 6, after 
 WCC remained normal but 
CRP rising.  
 Urea rising to 18.8  
 
 
 
fall):  within normal 
limits for age.     
Days 9-21 in ICU 
 MR head (day 15): 
bilateral 10 mm 
subdural hygromas, 
new in appearance 
compared to CT. No 
other abnormalities 
 Acetyl choline receptor, Anti 
MuSK, thyroid peroxidase, 
neuronal, voltage gated 
potassium channel and NMDA 
receptor antibodies negative 
 Auto-immune screen: normal 
 CRP (day 10): 56 mg/L (<5) 
 CSF examination (day 
10): normal 
 EEG (day 9): poorly 
tolerated: generalised 
slowing but no focal 
or epileptic features 
Table 1: Summary of investigations 
Discussion by Dr Jeremy Chataway  
I was hoping for a white matter case, perhaps MELAS, vanishing white matter disease or 
leucodystrophies 1  – but it’s not to be!  This is about an 83-year-old gentleman who presented to 
A&E and was a bit confused, had a normal CT head scan, then died within three weeks.  He was well 
in the period leading up to admission. 
So I thought I would introduce a Sherlock Holmes theme because Conan Doyle was of course born in 
Edinburgh and attended Edinburgh Medical School.  He began writing when no patients came to his 
practice and eventually after several moves set up an Ophthalmology practice near Baker Street - 
but again nobody came so he kept writing.  The rest is history and so you will see an astute almost 
Holmesian approach to this CPC!  
Gregory (Scotland Yard detective); “Is there any point to which you wish to draw my attention?”  
Sherlock Holmes; “The curious incident of the dog in the night-time”    
Gregory; “The dog did nothing in the night-time” 
Sherlock Holmes; “That was the curious incident”.  
 The Adventures of Silver Blaze. Sir Arthur Conan Doyle 1893 
 
“So eliminate all other factors and the one that remains must be the truth”  
    A Study in Scarlett. Sir Arthur Conan Doyle 1897 
And there are undeniable similarities between Professor Moriaty and Dr Richard Davenport, the 
organiser of this course.  ‘I’m going to break you Holmes, I’m going to bring off right under your nose 
the most incredible crime of the century, and you'll never suspect it until it's too late. That will be the 
end of you Mr. Sherlock Holmes. And when I've beaten and ruined you then I can retire in peace. I'd 
like to retire; crime no longer amuses me. I'd like to devote my remaining years to abstract science’.  
However, we must proceed with the case.   
His deterioration was rapid with visual hallucinations on a background of mild cognitive symptoms 
for a couple of years.  He had fairly standard general medical complaints: heart disease, prostate 
problems and GI disturbance and he was not on any medication. 
Mild cognitive impairment (MCI) 
First we will explore MCI and why and how that could that be important.   MCI is a function of age, 
but it can be on a spectrum that may progress to Alzheimer’s dementia (AD).  It is defined as a 
memory complaint when other aspects of cognitive function are within normal limits and activities 
of daily living are maintained. In patients with MCI the rate of development of AD is about 12% per 
year compared to about 2% per year in controls without MCI2.  
Visual hallucinations 
There are a number of conditions that cause visual hallucinations so maybe the answer lies here. 
Table 2 summarises some of the terms used to describe visual hallucinations/distortions and lists 
conditions that may cause visual hallucinations. 
Term Feature 
Tesselopsia/teichopsia Regularly repeating patterns 
Dendropsia  Branching patterns 
Hyperchromatopsia Perception of exceptionally wild and brilliant colours 
Polyopia Seeing a single target as multiple images 
Entomopia Rare form of polyopia when images seen as multiple rows 
and columns (insect vision) 
Macro/micropsia Images perceived as bigger or smaller than they actually 
are 
Metomorphosia Distorted images 
Palinopsia Image persists in visual field after stimulus has left the 
visual field 
Visual allesthesia Transportation of an object from one visual field to 
another 
Prosopometamorphosia Illusion of distorted faces 
Oscillopsia Objects in the visual field appear to oscillate 
Conditions associated with visual hallucinations: maybe the answer lies here. 
Delirium and delirium tremens, drugs and toxins, Dementia with Lewy Bodies and other 
parkinsonian syndromes, Alzheimer’s disease, Posterior Cortical Atrophy, epilepsy, 
sleep disorders and narcolepsy, migraine, Huntington’s disease, structural brain lesions, 
stroke, Prion diseases especially the Heidenhain CJD variant, Niemann-Pick disease, 
encephalitis, inborn errors of metabolism, visual impairment (Charles  Bonnet 
syndrome). 
Table 2: Different types of visual hallucination/disturbance and conditions that may cause visual 
hallucinations3 
Further analysis 
Initially he had a normal neurological examination and an AMT 9/10, but became confused and 
agitated requiring  lorazepam and haloperidol.  A few days later he was hypotensive with deranged 
electrolytes and AF, then became comatose requiring intubation.  Was this neurological disease or 
evidence of a more systemic illness?  The only neurological sounding symptom was nasal speech but 
no other signs were identified.  Myoclonic jerks were noted (day 9) raising the possibility of prion 
disease, but it could also be metabolic derangement or infection.  
Coma  
Consciousness requires arousal and awareness and depends on a functioning ascending reticular 
activating system and the cerebral cortex4.  Table 3 provides the features that distinguish 
encephalopathy and encephalitis.  In addition to structural causes of coma there are many others 
including metabolic derangement, seizures and infection. 
Encephalopathy Encephalitis (infectious or autoimmune) 
 Symptoms persisting at least 24 hours  
 Depressed or altered level of consciousness 
including: 
o Lethargy or 
o Extreme irritability or 
o Significant change in personality or 
behaviour and 
o no other cause found 
 Encephalopathy + two or more of 
o pyrexia >37.5 0C 
o seizure(s)  
o focal neurological findings  
o CSF pleocytosis (>5 WBC/microliter) 
o characteristic abnormal findings on 
neuroimaging (CT or MRI) 
Table 3: Criteria for diagnosing encephalopathy and encephalitis5 
Identifying the cause of coma 
Once general medical causes of coma have been excluded then primary neurological causes should 
be considered, either central or peripheral.  Patients might have both neurological and non-
neurological causes either simultaneously or sequentially.  In addition, there are important causes of 
encephalopathy not to overlook:  
1. Wernicke’s encephalopathy (triad of ophthalmoplegia, encephalopathy and gait ataxia): alcohol 
consumption may be denied or hyperemesis of pregnancy overlooked. The lesions of chronic 
Wernicke’s occur in a characteristic, symmetrical distribution in structures surrounding the aqueduct 
and the third and fourth ventricles.  It typically causes atrophy of the mammillary bodies and 
dorsomedial thalami.  Always remember that dextrose prior to thiamine replacement may 
precipitate Wernicke’s. Confusion is the most common symptom of Wernicke’s, followed by 
staggering gait and ocular problems but lethargy or coma may be the only symptom. 
2. Drugs; prescription drugs e.g. neuroleptic malignant syndrome, as well as illicit drugs.   
3. Trauma; isodense or hidden subdurals6.   
4. Common systemic infection can cause coma but rarer infections such as endocarditis or HIV can 
present as coma.  Be alert to relevant infectious causes in the returning traveller (e.g. malaria). 
5. Respiratory and metabolic derangements include: pulmonary causes (Obstructive Sleep Apnoea, 
hypercapnia, hypoxia and carbon monoxide poisoning); renal (uraemia and haemolytic uraemic 
syndrome); hepatic (acute liver failure or hepatic encephalopathy); haematological (thrombotic 
thrombocytopenic purpura, lupus anticoagulant syndrome); and endocrine (diabetic ketoacidosis or 
hypoglycaemia, hypothyroidism, hypercalcaemia, hyponatraemia, Hashimoto’s encephalopathy). 
More rare causes of coma, easily forgotten, include Addison’s disease (when the sodium may not be 
that low), insulinoma, phaeochromocytoma and non-CNS malignancy. Pseudo-coma due to 
psychogenic causes may occasionally catch out even the most experienced. 
In this case no medical cause was found: blood tests were normal, the chest x-ray showed signs of 
pneumonia but only as his condition deteriorated, and urine was sterile.  Therefore, it is likely to be 
a primary neurological cause of coma.  A clue may be the bilateral subdural hygromas seen on MR, 
not evident on CT.   However we would normally discount hygromas as a cause of pathology, 
although they are occasionally seen in conditions such as CNS lymphoma.  In this case I conclude 
that the imaging is unremarkable, and not offering diagnostic clues. As well as unremarkable 
imaging, the CSF and other blood tests were all within normal limits.   
“Stay with me here. Sherlock says it is a capital mistake to theorize before you have all the evidence. 
It biases the judgement”  
Rapidly progressive dementias 
Delirium should be considered in all patients presenting with acute fluctuating mental states such as 
disturbed attention, disorganised thinking and altered level of consciousness. Rapidly progressive 
dementias (RPD) are defined as dementias that evolve over days to weeks or sub acutely over 
months7.  Analysis from the five largest case series of RPD identified 675 patients, with a cause 
established in 95% of cases.  Over half of the cases were accounted for by CJD (58%), 
neurodegenerative conditions (e.g. AD 22%), with up to 19% being attributed to treatable causes 
(Wernicke’s, B12 deficiency and toxic/metabolic deficiencies)7.  
Our patient was noted to have visual hallucinations, which may suggest a neurodegenerative 
condition.  Table 4 summarises the neurodegenerative conditions that cause RPD but most of these 
are non-starters here as the duration from MCI to coma and death was so short.  AD is unlikely to be 
this rapid unless his decline had been begun earlier than his family realised, nor would it fit with 
MND or Corticobasal Degeneration, but Prion disease is possible (and of course we are at the home 
of Prion disease).   CJD can be extremely quick and deterioration to death within 25 days has been 
reported but a more typical duration would be 6 to 18 months7.  Ante-mortem diagnosis of Prion 
disease can be difficult and is based on: MRI (classically showing cortical ribboning, basal ganglia and 
thalamus hyperintensity on diffusion weighted imaging and fluid attenuated inversion recovery), 
EEG (generalised slowing and periodic polyspike-wave complexes and sharp waves which may not 
become apparent until late in the disease) and CSF analysis (normal or minimally raised WCC, total 
tau protein elevated to > 1200picograms/mL, protein 14.3.3 positive on Western blot. S100b may 
have a role in supporting a diagnosis if the clinical suspicion of CJD is high. RT-QuIC is currently being 
developed as an accurate pre-mortem diagnostic test). 
Neurodegenerative 
conditions 
Alzheimer’s disease (AD) 
Corticobasal degeneration (CBD)  
Dementia with Lewy bodies (DLB)  
Familial spastic paraparesis  
Frontotemporal degeneration (FTD)  
Motor neurone disease (MND)  
Progressive supranuclear palsy (PSP) 
Progressive subcortical gliosis 
Prion disease 
Autoimmune or 
Inflammatory 
conditions 
Acute disseminated encephalomyelitis(ADEM) 
Anti-body mediated brain disease 
Anti-GAD65 autoimmunity 
Behcet’s disease 
Coeliac disease 
Limbic encephalitis 
Multiple sclerosis (MS) 
Sjogren’s syndrome 
Steroid responsive encephalopathy 
Vascular Cerebral autosomal-dominant arteriopathy with sub 
acute infarcts and leukoencephlopathy (CADASIL) 
Cerebral amyloid angioathy 
CNS vasculitis 
Mitochondrial Encephalopathy with lactic acidosis and 
stroke like symptoms (MELAS) 
Strategic infarction 
Subdural haematoma 
Vascular dementia 
Metabolic disorders Cerebrotendinous xanthomatosis 
Extrapontine mylinosis 
Liver failure 
MELAS 
Neurodegeneration with brain iron accumulation (NBIA) 
Neuronal ceroid lipofuscinosis 
Nutritional deficiency (B1, B3, B12 or folate) 
Porphyria 
Uraemia 
Table 4: causes of rapidly progressive dementias7  
CNS Infections 
Could this be infection? A review of admissions to a neurological intensive care found the most 
common primary cause was infection8.  Herpes simplex virus (HSV) accounts for about 10% of the 
viral encephalitides8. Negative investigations for HSV do not completely exclude the diagnosis but 
should be considered a ‘red flag’ to prompt further investigation for other infectious causes such as 
VZV, EBV, CMV, measles, rubella, aborvirus, enterovirus, TB, fungal, parasitic (Toxoplasma and 
malaria), Rickettsia, Listeria and cryptoccocus.  Non-infectious causes should also be considered 
including CJD, paraneoplastic, and inflammatory conditions such as Behçet’s.  The normal CSF and 
brain imaging count against an infectious cause and, on balance I am discounting an infectious 
cause. 
Vascular 
Vascular causes such as stroke, venous sinus thrombosis and sub arachnoid haemorrhage are 
unlikely particularly in the context of normal imaging and progressive symptoms, but vasculitis is a 
background contender.  However, I would expect to see some abnormalities on the brain imaging 
and perhaps CSF.  
Paraneoplastic and neoplastic syndromes 
Another consideration would be a paraneoplastic syndrome9 typically associated with small cell lung 
cancer, breast cancer or germ cell tumours, and of course paraneoplastic syndromes can precede 
detectable tumours by months, sometimes years. Central paraneoplastic syndromes, such as 
cerebellar degeneration, are often associated with lung cancer.  Peripheral paraneoplastic 
syndromes such as LEMS also occur.   A central paraneoplastic brainstem encephalomyelitis would 
be high on my differential diagnosis and although anti neuronal antibodies were negative; it may be 
one that has not been tested.  However, we would normally expect the brain imaging to show 
abnormalities, particularly around the medial temporal lobes, but this is not always the case. The 
entirely normal CSF would be against a diagnosis of paraneoplastic encephalitis as we normally 
expect a lymphocytosis, oligoclonal bands or a raised protein.  Primary CNS malignancy such as 
lymphoma should also be considered. 
Autoimmune disease 
A further thought would be autoimmune encephalitis10 as the patient was confused and rapidly 
deteriorated to coma with few localising signs.  However the autoantibody screen was negative and 
therefore this is unlikely, but again it could be an autoantibody that has not been tested.  Imaging 
can be normal in about 40% of autoimmune encephalitis so don’t discount it as a diagnosis solely on 
normal imaging findings. 
As Sherlock would say in “The Sign of Four” (1890): 
“What seems strange to you is only so because you do not follow my train of thought or observe the 
facts upon which large inferences may depend.”   
Peripheral nervous system causes including the neuromuscular junction 
Disorders of the peripheral nervous system such as acute polyneuropathies, or of the neuromuscular 
junction such as myasthenia gravis, or drugs and toxins can lead to coma. The absence of focal signs 
on examination including the normal reflexes strongly point away from peripheral causes including 
Acute Inflammatory Demyelinating Polyradiculopathy (AIDP). However, the team did checked anti-
acetylcholine receptor and MuSK antibodies, which would suggest they had suspicions of a 
peripheral cause.  On balance the lack of signs would argue against the peripheral nervous system as 
the primary site of pathology.  This case therefore must have a central nervous system cause. 
Cardiac and respiratory diagnoses 
Were his new cardiac signs (AF) a clue to the diagnosis?  We know of neurological causes of cardiac 
signs following subarachnoid haemorrhage and ischaemic stroke.  Could endocarditis be the cause 
all along?  Probably not and I think AF was more of a reflection that he was old and ill with 
pneumonia.   
As Sherlock would say:  
“Eliminate the impossible, whatever remains however improbable must be the truth.” 
So two likely candidates remain: 
1. Paraneoplastic – the three-week time course to death would be possible however the negative 
antineuronal screen and the normal CSF would count against this diagnosis. 
2. Prion disease: sporadic CJD – but the speed seems a little quick although if we go back to the 
history it may be longer as he had an episode of nocturnal confusion and some cognitive change.  
Jeremy Chataway’s diagnosis 
Prion Disease – a home from home.  “There is nothing new under the sun: it’s all been done before”. 
Questions from the audience 
Q: How much alcohol did he consume? 
RD: His alcohol history was modest 
Q: Did you consider Lewy body as it can have an aggressive course? 
JC: Normally you would expect it to be initially reversible rather than this relentless aggressive 
decline into coma.  He was given an antipsychotic and it’s possible that accelerated his decline. 
Q: Would you expect to see fluctuations in prion disease? 
JC: No, but the fluctuations could be explained by superadded infection such as pneumonia. 
Q: Would you expect to see some signs in prion disease? 
JC: He was drowsy and dysarthric and by the time he was ventilated it would be difficult to identify 
signs or progression of signs. Myoclonus was noted. 
Q: What was the nature of the visual hallucinations? 
JS: He was wandering in a confused, aggressive and agitated state, and his hallucinosis appeared to 
involve people and objects.  This occurred within 12 hours of admission and was severe enough that 
the admitting team treated him with haloperidol and lorazepam.   
Q: Was there a history of sleep disturbance prior to admission? 
RD: This was not specifically asked about – I assume you are wondering about REM behavioural 
disturbance as the harbinger of an alpha-synucleinopathy? 
Q:  Is it possible for this to be autoimmune encephalitis with normal imaging and CSF? 
RD: Yes, all things are possible, although as Dr Chataway has identified, it would be unusual with all 
the tests being normal, as in this case. 
Audience diagnoses 
Half the audience agreed with a Prion disease diagnosis, paraneoplasia found much less favour.   
JS: A final comment prior to the denouement: the family were keen for the case to be presented and 
discussed at this CPC as a learning point.  They felt haloperidol was the cause of his rapid decline and 
were keen for a pathological diagnosis.   We are grateful them for allowing us to present this CPC. 
Pathology review by Dr Colin Smith 
Consent for a limited post mortem was obtained. Macroscopically the brain was a normal weight 
with mild symmetrical frontotemporal atrophy evident.  Microscopic examination of a number of 
brain regions using standard haematoxylin and eosin (H&E) stains identified significant 
cerebrovascular disease affecting the large leptomeningeal vessels with prominent, widespread 
atherosclerosis but no acute thrombus.  In addition, small vessel arteriolosclerosis was noted in a 
number of regions with some white matter rarefaction but no lacunar infarcts. 
Neuritic plaques and neurofibrillary tangles were obvious in the entorhinal cortex on H&E stain, and 
highlighted by β-amyloid and tau immunohistochemistry. There was no evidence of spongiform 
encephalopathy, but Lewy bodies were seen in the substantia nigra, with clear loss of pigmented 
neurones and extra neuronal pigment. -synuclein staining highlighted neuronal inclusions within 
the substantia nigra, along with Lewy neurites (abnormal parenchymal threads) (figure 1).  Striking 
and typical -synuclein pathology was also seen in the dorsal vagal nucleus (figure 2), and cortical 
Lewy bodies were noted (figure 3). In the occipital region there was evidence of cerebral amyloid 
angiopathy, but this was not seen in other brain areas.  This was mainly in the leptomeningeal and 
only occasionally the parenchymal vessels.   
In terms of staging of the Lewy body disease, which can be done using the either the Braak11 or 
consortium guidelines12, this is at least Braak stage 5 as the cingulate gyrus was involved and this 
would equate to the neocortical stage of Lewy body disease using consortium guidelines.  For 
Alzheimer’s disease associated pathology we can also use Braak staging for the neurofibrillary 
pathology and more recent guidelines also bring in amyloid with comments on Lewy body pathology. 
The AD pathology here is Braak stage I – II.   
Main pathological findings 
The final pathological diagnosis is therefore: diffuse Lewy Body Disease Braak stage 5; Alzheimer’s 
pathology Braak stage I – II; and cerebrovascular disease in the form of large vessel atherosclerosis, 
small vessel arteriolosclerosis and occipital cerebral amyloid angiopathy.  This is on a background of 
pneumonia and hypoxaemia causing brain hypoperfusion and led to the more widespread changes 
seen.   
Comments 
JC: Was it the combination of antipsychotics and systemic infection that resulted in his rapid decline? 
JS: A background of cerebrovascular disease and infection may explain the explosive onset and both 
are likely to have accelerated the process.  Exposure to antipsychotics may have played a part as 
well, although he did not develop the typical dramatic parkinsonism that is often the consequence of 
antipsychotic use in DLB. 
Q: So clinically was this Dementia with Lewy Bodies (DLB) or AD? 
CS: We frequently see Braak stage 1-2 Alzheimer’s pathology in patients who were said to be 
cognitively normal.  However we never see Braak stage 5 LBD in patients without clinical signs of 
LBD.  The aim of the McKeith consortium approach was to help answer this question with regard to 
the relative importance of either pathology as a cause of death.  This was a neocortical case and 
therefore the predominant pathology.  
RD: Clinically we can retrospectively acknowledge the rapid onset and visual hallucinosis as 
consistent with a diagnosis of DLB, and this is now supported by the pathology. 
Q: What are we attributing the myoclonus to? 
RD: It is not an uncommon finding in end stage cognitive disease. 
Q: Had he died of, say, a heart attack one month prior to this presentation, would the brain 
pathology have been the same? 
CS: Yes, the clinical picture was very rapid but the pathology would have been present before his 
decline.   
Final Clinico-Pathological Diagnosis 
Dementia with Lewy Bodies 
Dementia with Lewy Bodies. 
Lewy bodies are named after Frederick Lewy who in 1912 described abnormal intracytoplasm 
inclusions in a patient with Parkinson’s disease; cortical Lewy bodies were finally linked with a 
dementia in 196113.  Currently it is estimated that dementia affects 7% of people over the age of 65 
years and 30% of those older than 80 years14.  Dementia with Lewy bodies (DLB) is the second most 
common degenerative dementia accounting for 10-20% of cases at post-mortem14,15. If a patient has 
a progressive cognitive decline within a year of onset of motor parkinsonism then this is considered 
to be DLB13, although it is likely that DLB and PD associated dementia form a continuum.   
The main differential diagnosis in cases of DLB is AD, PD associated dementia, atypical PD syndromes 
such as progressive supra nuclear palsy or cortico-basal degeneration and Creutzfeldt-Jakob 
disease13.  In PD the distribution of Lewy bodies is subcortical and the progression of Lewy body 
pathology is usually in a caudal to rostral direction i.e. from nigra to limbic regions and finally to the 
neocortex16.  In contrast a more generalised distribution is seen in patients with DLB14.  Levo-dopa  
response is often poor in patients with DLB, and they can be acutely sensitive to even small doses of 
neuroleptic drugs17.   
Lewy body Pathology 
Lewy bodies are inclusion bodies containing mainly -synuclein and are probably markers of 
neuronal distress.  They are common in the ageing brain and are associated with neurodegenerative 
conditions16, but the role of Lewy bodies in disease is not straightforward.  A longitudinal community 
based clinical-pathological study of 872 subjects found 157 subjects with Lewy bodies in the 
substantia nigra, limbic and neocortical regions.  Of these 157 patients, 103 (66%) had a pathological 
diagnosis of AD but only half had detectable dementia at death and one third of people without 
Lewy body pathology had shown signs of dementia prior to death.  However, Lewy body pathology 
of the neocortical type was associated with increased odds of dementia and a more rapid decline in 
all cognitive domains, and limbic-type Lewy body pathology was associated with poor visuospatial 
skills16.  Not all patients with pathologically defined DLB are clinically demented.  
DLB should be suspected in older people with mild memory impairment and visual hallucinations but 
an early feature may be recurrent periods of confusion13,14,17.  Typically the episodic confusion is on a 
background of progressive cognitive deterioration with the fluctuations in cognition mainly 
associated with inattention and loss of alertness. Psychiatric manifestations occur early in the 
disease with visual hallucinations, delusions, apathy and anxiety being the most commonly 
reported13.  Hallucinations are usually vivid, colourful, three-dimensional and are generally mute 
images of animate objects.  They are recurrent and well formed, consisting of small animals, people 
or children.  Misperceptions such as mistaking carpet and wallpaper patterns for snakes is 
common3,13,14.  Visual hallucinations are associated with lower cortical acetylcholine levels and 
consequently may respond well to cholinesterase inhibitors.  Dizziness, pre-syncope, syncope and 
falls due to orthostatic hypotension or carotid sinus hypersensitivity are important other early 
symptoms that may support the clinical diagnosis.  In addition, prominent REM behavioural sleep 
disorder may be reported16.  A discussion of the full criteria for the diagnosis of DLB and the features 
that are useful in making a clinical diagnosis of DLB is available15.  
Rapidly progressive DLB 
Typically DLB has a progressive course with mean duration from symptom onset to death of 5-8 
years18.  However, case reports of rapid disease progression to death within 3-18 months of 
symptom onset can be found18 .  Diagnosis of DLB in patients with rapid cognitive decline can be 
extremely difficult because the neurological symptoms are non-specific and the investigations 
unremarkable.  Delirium at symptom onset may be a marker of rapidly progressive DLB, but no 
biological substrate has been identified to predict which patients will have a rapidly progressive 
course.  
A review of cases from a neurological tissue bank in Spain identified 83 pathologically confirmed 
cases of DLB (36 with a clinical diagnosis of PD with or without dementia and 47 with a clinical 
picture of DLB)18.  Of these 83 patients, six patients had a symptom onset to death of less than 18 
months (4 male: 2 female, mean age onset 72.5 years). Of these six, two were noted to have 
auditory hallucinations, four had mild Parkinsonism and three recurrent falls.  Three patients initially 
presented with an acute confusional state requiring emergency hospital admission.  Two of these 
three patients had mild cognitive symptoms for several months prior to onset and all had well-
formed visual hallucinations and structured delusions.  Action and spontaneous myoclonus were 
reported in three patients and two patients had a significant deterioration after treatment with 
antipsychotics.  Brain MRI scans revealed moderate atrophy but no cortical or basal ganglia 
abnormalities.  The pathological findings were diffuse Lewy body in all patients with 4 cases with 
neocortical-diffuse pathology and 2 limbic type pathology.  There were no atypical findings in terms 
of extension or severity of Lewy bodies or other pathology.  Five of the cases had coexisting AD type 
pathology (Braak stage II – VI), four had mild amyloid angiopathy and one had small vessel 
pathology18.   
Neuroleptic Sensitivity 
Up to 60% of demented patients in hospital receive antipsychotic medications17.  Patients with DLB 
may be particularly at risk of prolonged or permanent cognitive decline following surgery or 
exposure to antipsychotic mediation7.  Severe neuroleptic sensitivity is characterised by sudden 
onset sedation, increased confusion, immobility and muscle rigidity and up to 30-50% of patients 
with DLB experience severe reactions even at low doses which can be fatal within days to weeks13,15.   
Significant striatal α-synuclein pathology and neuronal loss or dysfunction within the putamen may 
provide the pathophysiological reason for neuroleptic sensitivity in patients with DLB and related 
parkinsonism conditions15.  A prospective study of patients exposed to antipsychotic medication 
included 15 patients with DLB; eight of the fifteen (53%) patients experienced severe neuroleptic 
sensitivity.  In another series of 20 demented patients with DLB who died in hospital, 80% (16/20) 
received antipsychotic medication and of these 81% (13/16) showed severe sensitivity to these 
medications and in 7 (54%), the reaction appeared to precipitate their terminal decline13. However, a 
history of neuroleptic tolerance is compatible with a diagnosis of DLB19. 
Conclusion 
Rapidly progressive dementias can be difficult diagnose as there may be few localising features and 
delirium is often suspected19.  Families may not have appreciated the proceeding progressive mild 
cognitive impairment and initial cognitive fluctuations are discounted or forgotten about, as they are 
often short-lived with a seemingly good recovery.  DLB typically has a slower course and may 
therefore be over-looked as a cause of RPD. 
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Figure 1a: -synuclein positive intra-neuronal inclusions and Lewy threads within the substantia 
nigra (-synuclein immunohistochemistry x40) 
Figure 2: Dorsal motor vagal nucleus α-synuclein pathology, with both intra-neuronal inclusions and 
threads (-synuclein immunohistochemistry x10) 
Figure 3: Cortical Lewy bodies within the cingulate gyrus, highlighted with -synuclein 
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